Experts in oncology and rare disease pathology.
We are dedicated to the success of your new therapeutic submission through comprehensive testing, expert pathologist interpretation, and professional project management that supports your clinical trial and subsequent U.S. Food and Drug Administration (FDA) submission.
ARUP’s team of experts work with our partners to determine patient eligibility for clinical trials and effectiveness of new therapeutics. This work is all completed through pathologic confirmation of diagnoses and response assessment managed following Good Clinical Practice (GCP) standards.
We offer a full suite of anatomic pathology testing services, including morphologic evaluation, immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and molecular diagnostics.
Our partners have access to nearly 100 nationally and internationally recognized medical directors, including experts in hematopathology, solid tumors, and molecular oncology.
Our diagnostic test results and their interpretation by our board-certified pathologists are used by our partners to secure FDA approval of new therapeutics in oncology.
We can assist with your project to ensure the highest probability of success.
Email firstname.lastname@example.org to get started.